Sanders Statement on New $373,000 Cancer Therapy
WASHINGTON, Oct. 19 – Sen. Bernie Sanders (I-Vt.) issued the following statement Thursday after the pharmaceutical company Gilead said the list price for the cancer drug Yescarta would be $373,000: “Gilead, one of the greediest pharmaceutical corporations in the world, is once again gouging Americans dealing with a life-threatening illness. This time, Gilead plans to charge an outrageous $373,000 per